Overactive Bladder
📧 Sign up to get email alerts when something new happens for Overactive Bladder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-07-17Clinical Trial Update: Optimal Injection Interval for Intra-Detrusor Botulinum Toxin [NA]
Clinical trial update on the optimal intradetrusor botulinum toxin injection interval for overactive bladder conditions; the study is not ye…
-
CLINICAL_TRIALS trial_result · 2024-07-03Clinical Trial Update: Posterior Tibial Transcutaneous Neurostimulation in Idiopathic Overactive Bladder
This entry reports a completed clinical trial evaluating posterior tibial transcutaneous neurostimulation for idiopathic overactive bladder.
-
CLINICAL_TRIALS trial_result · 2024-06-26Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of DA-8010 in Patients With Overactive Bladder [Phase 3]
Phase 3 study evaluating DA-8010 for overactive bladder has completed.
-
CLINICAL_TRIALS trial_result · 2024-06-13Clinical Trial Update: Urinary Symptoms After Posterior Tibial Nerve Stimulation
This update notes the completed status of a clinical trial evaluating urinary symptoms after posterior tibial nerve stimulation.
-
CLINICAL_TRIALS trial_result · 2024-06-13Clinical Trial Update: Transvaginal Radiofrequency Ablation for Overactive Bladder [NA]
This update reports a completed clinical trial evaluating transvaginal radiofrequency ablation for overactive bladder.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-05-31Clinical Trial Update: Evaluation of Efficacy and Patient Satisfaction of Local Anaesthesia Versus Sedoanalgesia for Botox (R) Injection in the Urinary Bladder for the Treatment of Idiopathic Overactive Bladder [NA]
This ClinicalTrials.gov entry describes an ongoing study evaluating the efficacy and patient satisfaction of local anaesthesia versus sedoan…
-
CLINICAL_TRIALS research · 2024-05-30Clinical Trial Update: Evaluation of Autonomic Nervous System Changes in Response to Stimulation by Sacral Neuromodulation [NA]
Clinical trial update evaluating autonomic nervous system changes in response to sacral neuromodulation for bladder dysfunction. The study s…
-
FDA approval · 2024-05-29FDA Approved: OXYTROL — Supplemental Application (Allergan, Inc.)
The FDA approved a supplemental application for OXYTROL (oxybutynin) by Allergan, Inc.
-
CLINICAL_TRIALS withdrawal · 2024-05-29Clinical Trial Update: A Sham-Controlled Study to Evaluate the Safety and Efficacy of a Smart, Self-Adjusting, Surgery-Free, Wearable Bladder Neuromodulation System for Overactive Bladder [NA]
A sham-controlled clinical trial evaluating a wearable bladder neuromodulation system for overactive bladder has been terminated.
-
CLINICAL_TRIALS research · 2024-05-24Clinical Trial Update: Antibiotic Usage Prior to OnabotulinumtoxinA Injection [NA]
Clinical trial status update showing recruiting for a study on antibiotic use prior to onabotulinumtoxinA injection for overactive bladder, …
-
CLINICAL_TRIALS trial_result · 2024-05-21Clinical Trial Update: OAB and the Microbiome
A University of Miami-sponsored clinical trial evaluating the relationship between the microbiome and overactive bladder/urgency-frequency s…
-
CLINICAL_TRIALS other · 2024-05-17Clinical Trial Update: Prostate Enucleation With Intravesical Botox Injections in Treating BPH and Bladder Overactivity [NA]
A clinical trial from Menoufia University is evaluating bipolar enucleation of the prostate with intravesical Botox injections for benign pr…
-
CLINICAL_TRIALS research · 2024-05-07Clinical Trial Update: Comparison of a Paper and Automated Bladder Diary in Pediatric Patients [NA]
This clinical trial aims to compare paper versus automated bladder diaries in pediatric patients with lower urinary tract symptoms and relat…
-
CLINICAL_TRIALS trial_result · 2024-05-03Clinical Trial Update: Repetitive Transcranial Magnetic Stimulation (rTMS) on Neurogenic Overactive Bladder in Stroke [NA]
The clinical trial evaluating repetitive transcranial magnetic stimulation for neurogenic overactive bladder in stroke has completed.
-
CLINICAL_TRIALS trial_result · 2024-05-03Clinical Trial Update: Study of ONO-8577 in Patients With Overactive Bladder [Phase 2]
A Phase 2 study evaluating ONO-8577 in patients with Overactive Bladder has completed.
-
CLINICAL_TRIALS research · 2024-04-26Clinical Trial Update: Transcutaneous Tibial Nerve Stimulation in Patients With Neurogenic Overactive Bladder After Stroke [NA]
A clinical trial update on transcutaneous tibial nerve stimulation for neurogenic overactive bladder after stroke, currently NOT_YET_RECRUIT…
-
CLINICAL_TRIALS research · 2024-04-16Clinical Trial Update: Impact of Decision Aids in Urogynecology [NA]
Clinical trial update on the impact of decision aids in urogynecology, completed with results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-03-08Clinical Trial Update: A Trial Evaluating the Clinical Efficacy and Safety of Hibero SR (Mirabegron) 50 mg and Ditropan (Oxybutynin Chloride) 10 mg in Children Between 5 and 18 Years With Overactive Bladder (OAB) [Phase 2]
Phase 2 trial evaluating Hibero SR (mirabegron) 50 mg and Ditropan (oxybutynin chloride) 10 mg for efficacy and safety in children aged 5-18…
-
FDA approval · 2024-02-28FDA Approved: TOVIAZ — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved a supplemental application for Toviaz (fesoterodine fumarate) from Pfizer Laboratories Div Pfizer Inc.
-
FDA approval · 2024-02-20FDA Approved: SOLIFENACIN SUCCINATE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved the original application for solifenacin succinate (Macleods Pharmaceuticals Limited), a generic version for the treatment of o…
-
CLINICAL_TRIALS trial_result · 2024-02-12Clinical Trial Update: Evaluation of Intradetrusor AbobotulinumtoxinA and IncobotulinumtoxinA in Women With Overactive Bladder [Phase 4]
Phase 4 trial evaluating intradetrusor abobotulinumtoxinA and incobotulinumtoxinA in women with overactive bladder has completed.
-
CLINICAL_TRIALS trial_result · 2024-02-02Clinical Trial Update: Higher Neural Changes Following Anticholinergic, Beta 3 Agonist, or Placebo in Patients With Overactive Bladder [Phase 4]
Phase 4 trial update comparing neural changes after anticholinergic, beta-3 agonist, or placebo in patients with overactive bladder
-
FDA approval · 2024-01-09FDA Approved: FESOTERODINE FUMARATE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approves Camber Pharmaceuticals' original application for fesoterodine fumarate (generic), enabling its marketing for overactive bladder…
-
CLINICAL_TRIALS trial_result · 2024-01-05Clinical Trial Update: InterStim Micro Post Market Clinical Follow-up Study (ELITE) [NA]
This clinical trial update reports the termination of Medtronic's InterStim Micro post-market follow-up study (ELITE) and notes that results…
-
CLINICAL_TRIALS trial_result · 2024-01-02Clinical Trial Update: Prophylactic Antibiotic Administration for Bladder OnabotulinumtoxinA Injection [Phase 4]
A Phase 4 trial evaluated prophylactic antibiotic administration to reduce infection risk associated with bladder injections of onabotulinum…